Moderna says bivalent booster performs better against BA.5 omicron subvariant

Hits: 12

Moderna released data from a Phase 2-3 clinical trial showing its bivalent COVID-19 booster shot performed better against the BA.4 and BA.5 omicron subvariants. Read More Go To Source